Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Thomas, McNerney & Partners is a healthcare venture capital and private equity firm that focuses on life sciences and medical technology investments across all stages of development. The firm provides growth capital, assists in spinning out products and divisions from major medical device and pharmaceutical companies, and participates in structured financings and recapitalizations. Established in 2001 by James E. Thomas and Peter H. McNerney, the firm is headquartered in Stamford, Connecticut, with additional offices in Minneapolis, Minnesota, and San Francisco, California.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Thomas, McNerney & Partners' most notable exit?
- Thomas, McNerney & Partners notably exited Galil Medical in May 2016 through an acquisition by BTG plc for $110M.
- Which sectors does Thomas, McNerney & Partners focus on for investments?
- Thomas, McNerney & Partners has a focus on the Health Tech & Life Sciences sector, as evidenced by their portfolio company Galil Medical.
- Can you name a key company in Thomas, McNerney & Partners' portfolio?
- A key company in Thomas, McNerney & Partners' portfolio was Galil Medical, which specializes in cryotherapy for cancer treatment.
- When did Thomas, McNerney & Partners make its investment in Galil Medical?
- Thomas, McNerney & Partners invested in Galil Medical in December 2006.
- What was the total amount raised by Galil Medical, a portfolio company of Thomas, McNerney & Partners?
- Galil Medical, a portfolio company of Thomas, McNerney & Partners, raised $52M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2001 |
|---|